Digestive System Neuroendocrine Carcinoma

Digestive System Neuroendocrine Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

48 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 9
Recruiting: 3
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: Alliance for Clinical Trials in Oncology
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (9)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05173246	JS001 Combined With TP as First-line Treatment for Unresectable or Advanced Small Cell Esophageal Carcinoma	recruiting	Phase 2	43	Sun Yat-sen UniversityOTHER	1	Jul 16, 2025	clinicaltrials
NCT06070740	First- Line Treatment With Durvalumab Plus XELOX Chemotherapy in Advanced Gastrointestinal Neuroendocrine Carcinoma	recruiting	Phase 2	22	Peking Union Medical College HospitalOTHER	1	Oct 6, 2023	clinicaltrials